Linsitinib inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion in orbital fibroblasts from patients with thyroid-associated ophthalmopathy
Author Information
Author(s): Lee Ji-Young, Lee Seong-Beom, Yang Suk-Woo, Paik Ji-Sun
Primary Institution: The Catholic University of Korea
Hypothesis
Does linsitinib inhibit IGF-1-induced proliferation of orbital fibroblasts via suppression of the PI3K/Akt and ERK pathways?
Conclusion
Linsitinib effectively inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
Supporting Evidence
- Linsitinib significantly reduced IGF-1-induced proliferation of orbital fibroblasts.
- Linsitinib inhibited the secretion of hyaluronic acid stimulated by IGF-1.
- Statistical analysis showed significant differences in cell proliferation and secretion levels.
Takeaway
Linsitinib is a medicine that helps stop certain cells in the eye from growing too much and making too much of a substance called hyaluronic acid, which can cause problems in people with a specific eye disease.
Methodology
The study involved treating human orbital fibroblasts with linsitinib and IGF-1, followed by assays to measure cell proliferation and hyaluronic acid secretion.
Potential Biases
Potential bias due to the limited sample size and the specific patient population studied.
Limitations
The study primarily focused on orbital fibroblasts from patients with TAO and did not include a broader range of controls.
Participant Demographics
Patients with thyroid-associated ophthalmopathy (TAO) and control subjects without TAO.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website